Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Clarus Therapeutics To Present New Real World Experience Data For Jatenzo Testosterone Undecanoate At The 22nd Annual Fall Scientific Meeting Of Smsna is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
On April 1, 2024, four new employees were awarded grants of options to purchase an aggregate of 22,400 shares of voting common stock (the “Options”). Each Option was granted ... Read More
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics ... today announced that new data on ATH434 will be presented at the World Orphan Drug Congress ... Read More
Dog Company Announces New Air Travel Experience Designed Specifically for Canines: They 'Will Be the VIPs'
Routes will currently serve the New ... the "world’s first air travel experience designed specifically for dogs first, and their human companions second," according to a press release obtained ... Read More
Ariceum Therapeutics to present new radioligand therapy data at American Association for Cancer Research (AACR) Annual Meeting 2024
Founded in 1907, the American Association for Cancer Research (AACR) is the world ... therapeutics-to-present-new-radioligand-therapy-data-at-american-association-for-cancer-research-aacr-annual ... Read More
STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024
Oliver Rausch, Chief Scientific Officer at STORM Therapeutics, said: "We are looking forward to presenting these data on our first-in-class METTL1 inhibitor at the AACR Annual Meeting. As we ... Read More
Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
A copy of the poster presentation will be made available under the Presentations tab of the Investors section of the Company’s website following the meeting at https://ir.plustherapeutics.com. Read More
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Two presentations highlighting data on DAXXIFY ... performance Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced two poster presentations on DAXXIFY® for the treatment of cervical ... Read More
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
As previously announced, three posters from the Company’s development pipeline will also be presented at the American Academy of Neurology (AAN) 2024 Annual Meeting taking place April 13-18 ... Read More
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ ... will participate in a virtual presentation at the 23rd Annual Needham Virtual Healthcare Conference on Thursday ... Read More
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX ... today announced that new data on ATH434 will be presented at the World Orphan Drug Congress USA ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus